facebook-page-view
Advertisement

Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds

By Sreeja Biswas

  • 05 Jan 2024
Premium
Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds
Credit: 123RF.com

Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI Venture way back in 1996 when PE was a new term in India.    Today, the drugmaker counts Indian PE firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement